2seventy bio, Inc. (TSVT) Financials
Stock symbol TSVT is outdated, potentially delisted? Maybe it is available on other exchange?
TSVT Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2025 | 480.0 million | 266.0 million |
| Dec. 31, 2024 | 479.5 million | 268.7 million |
| Sept. 30, 2024 | 503.8 million | 275.7 million |
| June 30, 2024 | 517.9 million | 283.1 million |
TSVT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2025 | -11.0 million | 2.2 million |
| Dec. 31, 2024 | -9.5 million | 2.4 million |
| Sept. 30, 2024 | -10.5 million | 2.6 million |
| June 30, 2024 | -23.2 million | 2.4 million |
TSVT Net Income
No data available :(
TSVT Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2025 | 170.4 million | 223.0 million | 239.8 million |
| Dec. 31, 2024 | 174.8 million | 227.4 million | 227.4 million |
| Sept. 30, 2024 | 192.4 million | 231.6 million | 247.4 million |
| June 30, 2024 | 201.9 million | 235.9 million | 251.4 million |
TSVT Shares Outstanding
TSVT Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2025 | - | 5.4 million | 14.8 million | - |
| Dec. 31, 2024 | - | 8.7 million | 8.5 million | - |
| Sept. 30, 2024 | 34000 | 8.3 million | 12.9 million | - |
| June 30, 2024 | 61000 | 16.0 million | 9.9 million | - |
TSVT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2025 | 22.9 million | 8.8 million |
| Dec. 31, 2024 | 2.9 million | 8.8 million |
| Sept. 30, 2024 | 13.5 million | 5.8 million |
| June 30, 2024 | 9.0 million | 3.5 million |
TSVT Revenue by Segment
Graph available only for paid members. Upgrade to see it.
TSVT
Price: $5
52 week price:
Earnings Per Share: -0.08 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 673900
Market Capitalization: 266.1 million